| Identification | Back Directory | [Name]
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine | [CAS]
128495-99-8 | [Synonyms]
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-b-D-arabinocytidine
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine
’,5’-Di-O-benzoyl-2’-deoxy-2’-fluoro-alpha-D-arabino-cytidine
3’,5’-Di-O-benzoyl-2’-deoxy-2’-fluoro-alpha-D-arabino-cytidine
1-(3,5-O-Dibenzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)cytosine
1-(3,5-O-DIBENZOYL-2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)CYTOSINE
2(1H)-Pyrimidinone, 4-amino-1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-
4-Amino-1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone | [Molecular Formula]
C23H20FN3O6 | [MDL Number]
MFCD25542521 | [MOL File]
128495-99-8.mol | [Molecular Weight]
453.42 |
| Hazard Information | Back Directory | [Uses]
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|